PPAR activation and increased fatty acid metabolism were observed in SHRs after 4 months treatment of medium-chain triglycerides, accompanied by reduction of oxidative stress and improvement of myocardial hypertrophy (Saifudeen et al., 2017). Here, PPARA is linked to cardiac hypertrophy.